High Calcium After Parathyroid Surgery: Could It Be FHH1?
At a Glance
Persistent high blood calcium after parathyroid surgery may be caused by an inherited genetic condition called FHH1 rather than a missed tumor. Because FHH1 alters the body's calcium thermostat, surgery cannot fix it. A CASR genetic test is required for a definitive diagnosis.
In this answer
4 sections
If you had parathyroid surgery for suspected primary hyperparathyroidism (PHPT) but your blood calcium levels remain high, your doctor will likely look for a missed or “ectopic” (hidden) parathyroid tumor first. However, if no tumor is found, it is entirely possible that you have undiagnosed Familial Hypocalciuric Hypercalcemia type 1 (FHH1) instead. FHH1 is sometimes misdiagnosed as primary hyperparathyroidism because the two conditions look very similar on basic blood tests [1]. Unfortunately, this means some people with FHH1 undergo unnecessary parathyroid surgery before finally getting the correct diagnosis [2][3]. It is a frustrating path, but understanding why the surgery failed is the first step toward getting the right answers.
Why Parathyroid Surgery Does Not Fix FHH1
To understand why the surgery did not lower your calcium, it helps to look at the difference between how these two conditions behave:
- Primary Hyperparathyroidism (PHPT) is usually caused by a benign tumor (an adenoma) on one or more of your parathyroid glands. This tumor goes rogue, pumping out too much parathyroid hormone and driving up your blood calcium. Surgery works for PHPT because the surgeon removes the problem tumor.
- FHH1 is not caused by a tumor. It is a lifelong genetic condition caused by an inherited mutation in the Calcium-Sensing Receptor (CASR) gene [4].
The protein made by your CASR gene acts as your body’s calcium “thermostat.” In FHH1, the mutation changes the thermostat’s set-point, so your body thinks it needs a higher level of calcium in the blood to function normally [4][5]. Because this altered thermostat affects the sensing mechanism in all of your parathyroid glands and your kidneys, removing some of the parathyroid tissue does not fix the underlying genetic rule your body is following [6][7]. The remaining tissue will simply continue to keep your blood calcium at that higher, mutant set-point.
How Misdiagnoses Happen
Because FHH1 is much rarer than primary hyperparathyroidism, doctors often assume high calcium and normal-to-high parathyroid hormone levels point to PHPT [1].
Doctors usually use a 24-hour urine collection test (which involves collecting all of your urine in a jug for a full day) to calculate a Calcium-to-Creatinine Clearance Ratio (CCCR) to screen for FHH1 before surgery [8]. People with FHH1 generally excrete very little calcium in their urine (a CCCR typically less than 0.01), while people with PHPT excrete more (typically greater than 0.02) [9]. However, this test is not perfect. Some patients with FHH1 have urine calcium levels that fall into a “grey zone” (between 0.01 and 0.02) overlapping with those seen in PHPT, which can lead to a misdiagnosis and an ineffective surgery [1][10].
Getting a Definitive Answer
If your calcium is still high after surgery, it is crucial to determine exactly what is causing it to avoid any further unnecessary operations [2].
The only way to definitively diagnose FHH1 is through genetic testing [11][12]. By taking a blood or saliva sample, a laboratory can sequence your CASR gene to look for the mutation [13]. Your endocrinologist might also order a panel that checks for related rare mutations (like FHH2 and FHH3) at the same time. You should request this specific genetic testing to confirm whether FHH1 is the true cause of your persistent high calcium.
What Does This Mean for You and Your Family?
If you are diagnosed with FHH1, it is natural to wonder what this means for your daily life and your loved ones. FHH1 is an autosomal dominant condition, which means that each of your children, siblings, and parents has a 50% chance of sharing the same mutation [14][15]. A confirmed diagnosis will allow your family members to undergo simple genetic screening to avoid the same surgical missteps.
In terms of long-term management, FHH1 is typically a benign, lifelong condition that does not cause the severe bone and kidney complications associated with PHPT [16][6]. For most patients, it requires no surgical treatment and no special diets; everyday clinical management is usually limited to observation and simply living with a higher “normal” calcium level [6]. In rare cases where hypercalcemia is exceptionally severe and causing symptoms, doctors may prescribe specific medications (like calcimimetics) to help regulate the calcium sensing mechanism [17][18].
Common questions in this guide
Why is my calcium still high after parathyroid surgery?
How is FHH1 different from primary hyperparathyroidism?
What test is used to definitely diagnose FHH1?
Is FHH1 dangerous if left untreated?
Will my family members need to be tested for FHH1?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since my calcium is still high after surgery, could we order a CASR genetic testing panel to rule out FHH1, FHH2, and FHH3?
- 2.Did my surgical pathology report show a clear parathyroid adenoma (tumor), or was the tissue normal?
- 3.What was my calcium-to-creatinine clearance ratio (CCCR) before the surgery, and does it fall into the 'grey zone' for FHH?
- 4.If the genetic test is positive, what is the best way to notify and screen my immediate family members?
- 5.How often will we need to monitor my blood calcium and kidney function going forward?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Is biochemical screening enough to guide calcium-sensing receptor gene mutational analysis when diagnosing familial hypocalciuric hypercalcemia? A retrospective study.
Flaris AN, Julsrud TO, Vierkant RA, et al.
Surgery 2025; (177()):108840 doi:10.1016/j.surg.2024.07.077.
PMID: 39389817 - 2
Familial hypocalciuric hypercalcaemia type 1 caused by a novel heterozygous missense variant in the CaSR gene, p(His41Arg): two case reports.
Courtney A, Hill A, Smith D, Agha A
BMC endocrine disorders 2022; (22(1)):324 doi:10.1186/s12902-022-01231-z.
PMID: 36536367 - 3
[First Report of a Family with Familial Hypocalciuric Hypercalcemia in Chile: Differential Diagnosis in a Patient with PTH-Dependent Hypercalcemia Post-Parathyroidectomy].
Valenzuela R F, González V G
Revista medica de Chile 2024; (152(3)):407-412 doi:10.4067/s0034-98872024000300407.
PMID: 39450845 - 4
Case report: familial hypocalciuric hypercalcemia.
Al-Ramdhan A, Al-Ashwal A, Albagshi H, et al.
AME case reports 2024; (8()):55 doi:10.21037/acr-23-132.
PMID: 38711891 - 5
Heterozygous Mutation (Q459R) in the Calcium-Sensing Receptor Gene Causes Familial Hypocalciuric Hypercalcemia 1 (FHH1).
Boisen IM, Mos I, Lerche-Black EM, et al.
The Journal of clinical endocrinology and metabolism 2020; (105(4)) doi:10.1210/clinem/dgz205.
PMID: 32160303 - 6
Novel mutations of the calcium-sensing receptor impede differential diagnosis of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.
Bhangu JS, Baumgartner-Parzer S, Hargitai L, et al.
Gland surgery 2022; (11(1)):12-22 doi:10.21037/gs-21-577.
PMID: 35242665 - 7
Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ, Lourenço DM
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2017; (49(11)):805-815 doi:10.1055/s-0043-120670.
PMID: 29136674 - 8
Urinary Calcium Measurement in Patients With Hypercalcaemia; Endocrine Physicians and Surgeons Survey Results From UK.
Arshad MF, Balasubramanian SP
Clinical endocrinology 2025; (103(5)):757-760 doi:10.1111/cen.70008.
PMID: 40754794 - 9
Factors influencing pre-operative urinary calcium excretion in primary hyperparathyroidism.
Kaderli RM, Riss P, Geroldinger A, et al.
Clinical endocrinology 2017; (87(1)):97-102 doi:10.1111/cen.13348.
PMID: 28383779 - 10
Efficacy of calcium excretion and calcium/creatinine clearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Bhangu JS, Selberherr A, Brammen L, et al.
Head & neck 2019; (41(5)):1372-1378 doi:10.1002/hed.25568.
PMID: 30554440 - 11
[Novel mutations in the calcium-sensing receptor encoding genes as a cause of familial hypocalciuric hypercalcemia].
Sarli M, Genovesi E, Levi L, Robbiani D
Medicina 2025; (85(2)):429-433.
PMID: 40198177 - 12
Novel Mutation in the Calcium-Sensing Receptor Gene Associated With Familial Hypocalciuric Hypercalcemia.
Al Kayed HA, Islam SU, Akanmode OJ, et al.
Cureus 2024; (16(8)):e66498 doi:10.7759/cureus.66498.
PMID: 39246902 - 13
A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.
Sumida A, Iizuka K, Kato T, et al.
BMC endocrine disorders 2022; (22(1)):164 doi:10.1186/s12902-022-01077-5.
PMID: 35733207 - 14
A novel homozygous c.301T > C, p.Y101H variant in the GNA11 gene is implicated in familial hypocalciuric hypercalcemia type 2 in a proband with the heterozygous variant present in mother and father - A case report.
Koca SB, Balta B
Scandinavian journal of clinical and laboratory investigation 2025; (85(8)):670-674 doi:10.1080/00365513.2025.2588772.
PMID: 41240382 - 15
A novel homozygous mutation of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
Li N, Li X, Ni XL, et al.
Chinese medical journal 2021; (134(15)):1869-1871 doi:10.1097/CM9.0000000000001568.
PMID: 34397587 - 16
Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
Marstrand SD, Tofteng CL, Jarløv A, et al.
Journal of medical case reports 2021; (15(1)):471 doi:10.1186/s13256-021-03051-6.
PMID: 34556169 - 17
Two Cases of Symptomatic Familial Hypocalciuric Hypercalcemia: Treatment Response to Calcimimetic Therapy.
Shakesprere J, Shafiq R, Madahar I, et al.
JCEM case reports 2024; (2(6)):luae096 doi:10.1210/jcemcr/luae096.
PMID: 38832006 - 18
Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature.
Koca SB
The Turkish journal of pediatrics 2023; (65(5)):853-861.
PMID: 37853976
This page provides educational information on why calcium levels may remain high after parathyroid surgery. Always consult your endocrinologist or surgeon for an accurate diagnosis and before pursuing genetic testing.
Get notified when new evidence is published on Familial hypocalciuric hypercalcemia type 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.